赵佳,霍勇,李春洁

• 1:天津市胸科医院心内科
• 2:北京大学第一医院心内科

摘要(Abstract)：

<正>ST段抬高型心肌梗死(ST-segment elevationmyocardial infarction, STEMI)是心血管疾病最为凶险的类型之一。《中国心血管病报告2018》概要指出,STEMI的发病率及死亡率逐年上升,并呈年轻化趋势~([1])。现阶段STEMI再灌注治疗主要有两种方法,分别是药物溶栓治疗和直接经皮冠状动脉介入治疗(percutaneous coronary intervention, PCI)。由于STEMI起病急、进展快、救治时间窗短,尽快开通闭塞血管达到有效的心肌再灌注是STEMI救治的核心~([2])。直接PCI是一种充分完全的再灌注治疗,但受限于医疗条件、地理位置及技术水平等因素,难以在我国基层医院广泛实施。为提高我国STEMI患者救治率,缩短再灌注时间,改善患者预后,

关键词(KeyWords)： ST段抬高型心肌梗死;溶栓;经皮冠状动脉介入治疗

Abstract:

Keywords:

基金项目(Foundation): 国家重点研发计划项目（2016YFC1301100）;; 天津市科技发展战略研究计划项目（18ZLZXZF00090）;; 天津市科技重大专项与工程项目(15ZXHLSY00320)

作者(Author): 赵佳,霍勇,李春洁

参考文献(References)：

• [1]胡盛寿，高润霖，刘力生，等.《中国心血管病报告2018》概要.中国循环杂志，2019, 34(3):209-220.
• [2]何奔，韩雅玲.中国ST段抬高型心肌梗死救治现状及应有对策.中华心血管病杂志，2019,47(2):82-84.
• [3] Rogers WJ, Baim DS, Gore JM, et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction(TIMI)PhaseⅡ-A trial. Circulation, 1990,81(5):1457-1476.
• [4] Werf FVD, Ross A, Armstrong P, et al. Primary versus tenecteplase-f acilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial inf arction(ASSENT-4 PCI):randomised trial. Lancet,2006, 367(9510):569-578.
• [5] Montalescot G, Ellis SG, de Belder MA, et al. Enoxaparin in primary and facilitated percutaneous coronary intervention A formal prospective nonrandomized substudy of the FINESSE trial(Facilitated intervention with Enhanced Reperfusion Speed to Stop Events). JACC Cardiovasc Interv, 2010, 3(2):203-212.
• [6]张文娟，张云盛.急性ST段抬高型心肌梗死的介入时机选择.天津医药，2017,45(11):1130-1134.
• [7] Sutton AG, Campbell PG, Graham R, et al. A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction:the Middlesbrough Early Revascularization to Limit INfarction(MERLIN)trial. J Am Coll Cardiol, 2004, 44(2):287-296.
• [8] Carver A, Rafelt S, Gershlick AH, et al. Longer-term followup of patients recruited to the REACT(Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis)trial. J Am Coll Cardiol, 2009, 54(2):118-126.
• [9] Armstrong PW, Gershlick AH, Goldstein P, et al. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med, 2013, 368(15):1379-1387.
• [10] Ibanez B, James S, Agewall S, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation:The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC). Eur Heart J,2018,39(2):119-177.
• [11] Armstrong PW. A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction:the WEST(Which Early ST-elevation myocardial infarction Therapy)study. Eur Heart J,2006, 27(13):1530-1538.
• [12] Di Mario C, Bolognese L, Maillard L, et al. Combined abciximab reteplase stent study in acute myocardial infarction(CARESS in AMI). Am Heart J,2004,148(3):378-385.
• [13] Yan AT, Yan RT, Cantor WJ, et al. Relationship between risk stratification at admission and treatment effects of early invasive management following fibrinolysis:insights from the trial of routine angioplasty and stenting after fibrinolysis to enhance reperfusion in acute myocardial infar. Eur Heart J,2011, 32(16):1994-2002.
• [14]张维，武利军.静脉溶栓联合PCI在STEMI救治中的探索历程及展望.中国循证心血管医学杂志，2017, 9(4):504-506.
• [15]颜红兵，向定成，刘红梅，等. ST段抬高型急性心肌梗死院前溶栓治疗中国专家共识.中国介入心脏病学杂志，2018,26(4):181-190.
• [16]张邦滢，刘莲莲，李广平，等.胸痛中心模式对急性ST段抬高型心肌梗死治疗方式及近期预后的影响.中国介入心脏病学杂志，2018,26(9):528-534.
• [17]王庆，汪雁博，郝国贞，等.急性ST段抬高型心肌梗死患者不同再灌注治疗策略的疗效研究.中国介入心脏病学杂志，2019,27(9):510-516.
• [18]国家心血管病中心.中国心血管病报告2017.北京：中国大百科全书出版社，2017:33-36.